Panhypopituitarism

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Panhypopituitarism trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT00001595

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central…

United States2,000 participantsStarted 1997-04-21

Treatment: MRI, Tissue specimen collection

RecruitingPhase 3

NCT06760546

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger,…

United States39 participantsStarted 2025-09-23

Treatment: Setmelanotide, Placebo

All recent trials (12 shown)

CompletedPhase 4

NCT04897802

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Oxytocin (OT) is a hypothalamic peptide that enters the peripheral circulation via the posterior pituitary gland. OT plays a key role in regulating appetite, ps…

Spain42 participantsStarted 2021-09-13

Treatment: Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration

CompletedNot Applicable

NCT05687474

Baby Detect : Genomic Newborn Screening

Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…

Belgium6,824 participantsStarted 2022-09-01

Panhypopituitarism

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

All recent trials (12 shown)

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Baby Detect : Genomic Newborn Screening

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

All recent trials (12 shown)

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Baby Detect : Genomic Newborn Screening

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Growing up With the Young Endocrine Support System (YESS!)

Incidence of cCPHD in Denmark - a National Observational Study

Growth Hormone and Endothelial Function in Children

Testosterone Gel Applied to Women With Pituitary Gland Problems

Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal…

Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma